Follow Fluence Energy to never miss an important update.
Hagens Berman has filed a lawsuit claiming the company gave false assurances about its manufacturing readiness while struggling to get its Houston facility up and running. The suit argues that these delays were at odds with management's public claims that they were ready to meet high demand from data centers. Lawsuits like this are common after a sharp drop in stock price and often take years to resolve. While it adds to the current noise around the company's recent leadership changes and production hurdles, these cases rarely result in a material hit to the business itself unless they uncover new, systemic fraud.
Source: Newsfile Corp
Julian Nebreda has stepped down as CEO and board member, and Ahmed Pasha has departed as CFO, both effective October 30. The company named Axel Meier, a longtime Siemens executive, as interim CEO and Ricardo Roizen as interim CFO. While the filing states the CEO's departure was not due to a disagreement, replacing both top leaders at once with interim appointments is a disruptive move.
This leadership shakeup comes as the company tries to turn a massive $5.6 billion backlog of orders into actual profit. The board also created a new committee to oversee manufacturing and operations, suggesting a sense of urgency in fixing how the business builds and delivers its battery systems. For long-term owners, this signals that the prior leadership may not have been moving fast enough to reach the company's profit goals. Fluence is now leaning on veterans from its founding partners, Siemens and AES, to steady the business.
Source: 8-K filing
After Fluence Energy reported its August results, we updated our fair value and cut our quality score to 1.9. We lowered our assessment of the team running the company and how well the business is protected from competitors. We have added the sudden departure of both the chief executive and chief financial officer to the risks we track. We also added the risks of relying on a small number of factories after production delays pushed 400 million dollars of revenue into next year. We reset our expectations for profit after the company moved from expecting a 50 million dollar gain this year to a 10 million dollar loss.
UBS set a $6 price target on the stock while keeping a neutral rating, which means they do not see a strong reason to buy or sell right now. This target is roughly in line with where the stock is currently trading. While the average analyst target for the company sits higher at $10, several firms have been lowering their expectations lately. This move reflects a cautious stance as the company works to turn its large backlog of signed contracts into actual revenue and profit.
Source: UBS
Truist Financial nudged its price target down to $8, though it kept its overall rating on the stock. This move follows a period of heavy selling that has seen the stock price fall significantly below the average analyst target, which now sits at about $10. A price target is just an analyst's estimate of where the stock will be in a year. While this lower target reflects the recent drop in share price, it does not change the firm's fundamental view of the business.
Source: Truist Financial
Management has missed its own targets in five of the last eight quarters. This choppy record and the recent exit of top leaders suggest the business is currently too unpredictable to forecast reliably.
| Expectation | |
|---|---|
| EPS | $-0.54 |
| Revenue | $812M |
Follow Fluence Energy to get the latest and most important updates.
Follow FLNC